Generate RSS
Generate RSS Feed Link
Select Departments for RSS Feed
Only departments with active upcoming events are listed. If you do not see a department listed, there are no upcoming events on that department's calendar.
Pharmacology
OB / Gyn
Center for Health Humanities and Ethics
Biochemistry, Molecular Biology and Genetics
Cancer Center
Orthopaedic Surgery
Office of Research Core Administration
Cancer Center Seminar Series
Cancer Center Research Program Events
Diversity & Community Engagement

Select Areas for RSS Feed
Only areas with active upcoming events are listed. If you do not see an area listed, there are no upcoming events tagged in that area.
Charlottesville
Prince William

Select Services for RSS Feed
Only services with active upcoming events are listed. If you do not see a services listed, there are no upcoming events tagged for that services.
Pregnancy & Birth
Joint Replacement Classes

Select timespan of RSS Feed events to display
By default, the RSS feed displays events in the 2 upcoming weeks from the current date. Use the controller below to increase the display time span. Select "0" for no limit.
Weeks to display

RSS Feed Link
Use the copy button below to copy the RSS feed link to paste into your web page. Use the preview button to view a plain text representation of what the feed will include. NOTE: RSS formatting is not applied to the data preview.

Preview RSS Feed Data
Manage
- My Event Notifications
- Add / Edit Events
  (for calendar administrators)

CIC Seminar Series - Gerald Linette, MD, PhD, University of Pennsylvania, Title: Melanoma Neoantigen Discovery and Clinical Validation

Sponsored by department(s) : Carter Immunology Center

Event Date : October 8, 2018

Start Time : 4:00 pm

Time Duration: 60 minutes

Location : Pinn Hall 1-17

Description : CIC Seminar Series - Gerald Linette, MD, PhD, University of Pennsylvania, Title: Melanoma Neoantigen Discovery and Clinical Validation

CME : No

Registration : No registration is necessary

Contact : Shawn Wood

Event Type(s) : Seminar

Audience : Everyone,